MOBI — Mobia Medical, Inc. Common Stock stock price, charts and financials

QT30Mobia Medical, Inc. Common Stock

Mobia Medical, Inc. Common Stock (NASDAQ: MOBI) is a Healthcare company in the Medical - Specialties industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
11.84
+0.49+4.32%
OverviewShort InterestFilings
MOBIQT30Mobia Medical, Inc. Common Stock·NASDAQ
11.84+4.32%
TA
Loading chart...
Screen all →
MASS+0.36%$8.45SI+1.39%$22.69STE+0.09%$232.85ALC+1.11%$70.99ATR-0.43%$136.18QGEN+0.00%$42.33PTGX+2.67%$135.81HQY+0.58%$104.97
Snapshot
Index-P/E-EPS (ttm)-Insider Own-Shs Outstand33.25MPerf Week10.45%
Market Cap393.67MForward P/E-EPS next Y-2.17Insider Trans-Shs Float2.06MPerf Month-10.64%
Enterprise Value367.67MPEG-EPS next Q-Inst Own-Short Float1.27%Perf Quarter-
Income-46.00MP/S12.30EPS this Y-Inst Trans-Short Ratio1.88Perf Half Y-
Sales32.00MP/B-EPS next Y19.63%ROA-96.57%Short Interest422.39KPerf YTD-15.43%
Book/sh-4.54P/C11.58EPS next 5Y-ROE30.84%52W High15.29 -22.56%Perf Year-
Cash/sh1.02P/FCF-EPS past 3/5Y-ROIC-121.06%52W Low10.19 16.19%Perf 3Y-
Dividend Est.-EV/EBITDA-Sales past 3/5Y-Gross Margin80.59%Volatility7.48% 7.84%Perf 5Y-
Dividend TTM-EV/Sales11.49EPS Y/Y TTM-Oper. Margin-144.71%ATR (14)0.93Perf 10Y-
Dividend Ex-Date-Quick Ratio4.01Sales Y/Y TTM-Profit Margin-145.12%RSI (14)49.25Recom2.00
Dividend Gr. 3/5Y-Current Ratio4.54EPS Q/Q-SMA201.71%Beta-0.28Target Price25.00
Payout0.00%Debt/Eq-Sales Q/Q-SMA50-5.93%Rel Volume0.54Prev Close11.35
Employees167LT Debt/Eq-0.05EarningsAug 11SMA200-5.46%Avg Volume190.72KPrice11.84
IPO DateMay 08, 2026Option/ShortNo / YesEPS/Sales Surpr.-2.77% 0.05%Net Debt/EBITDA0.54Volume102,266Change4.32%
Analyst Ratings
DateActionAnalystRatingTarget
Jun-02-26InitiatedBTIGBuy$19
Jun-02-26ReiteratedGoldman Sachs$31
Latest News
Aug-03-26
Aug-03-2604:05PM
Mobia Medical Appoints Myriam Curet, M.D., to its Board of Directorsglobenewswire.com
Jul-21-26
Jul-21-2604:05PM
Mobia Medical to Report Second Quarter 2026 Financial Results on August 11, 2026globenewswire.com
Jul-15-26
Jul-15-2604:05PM
Mobia Medical Appoints Reza Zadno, Ph.D., to its Board of Directorsglobenewswire.com
Jul-14-26
Jul-14-2604:20PM
Mobia Medical Announces Publication Of 2-Yr Follow-Up Data From VNS-REHAB Study In Neurology, Official Peer-Reviewed Journal Of American Academy Of NeurologyBenzinga
04:18PM
Mobia Medical Announces Publication of Two-Year Data from VNS-REHAB Trial Demonstrating Durable and Continued Stroke Recovery with Vivistim® Paired VNS™ Therapyglobenewswire.com
Jul-02-26
Jul-02-2604:42PM
Mobia Medical Says CMS Proposes To Maintain Vivistim CPT Code 64568 Under New Technology APC 1580 With ~$45,000 Outpatient Payment Rate For 2027Benzinga
04:35PM
Mobia Medical Announces Vivistim® Procedure Remains Assigned to New Technology APC 1580 under CMS Proposed 2027 Hospital Outpatient Prospective Payment System Ruleglobenewswire.com
Company

Mobia Medical, Inc. functions as a commercial-level medical device enterprise, concentrating on developing therapeutic solutions for individuals recovering from strokes who experience motor impairments. The company was established on March 5, 2007, by its founders Lawrence James Cauller, Navzer Engineer, Thomas Jordan Curnes II, and William Michael Rosellini, and it maintains its corporate headquarters in Austin, Texas.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
FY 2025
12/31/2025
Total Revenue32
Cost of Goods Sold Incl. D&A6
Gross Profit26
Selling, General and Administrative Excl. Other66
Research and Development7
Other Operating Expense-1
Operating Income-46
Interest Expense1
Unusual Expense
—
Non-Operating Income (Expense)1
Net Income Before Taxes-46
Income Taxes
0
Consolidated Net Income-46
Net Income From Continuing Operations-46
Net Income-46
EPS (Recurring)-1.41
EPS (Basic, Before Extraordinaries)-1.41
EPS (Diluted)-1.41
EBITDA-46
Other After Tax Adjustments
—
Stock Option Compensation Expense
—
Price To Earnings Ratio
—
Price To Sales Ratio
—
Gross Margin81.25
Operating Margin-143.75
Net Margin-143.75
Shares Outstanding33
Market Capitalization
—
Operating Lease Expense
—
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.